Bellevue Life Sciences Acquisition - Units (1 Ord, 1 War & 1 Right ) Profit Margin

Bellevue Life Sciences Acquisition - Units (1 Ord, 1 War & 1 Right )'s profit margin stands at 671.56% as of June 2026. That compares with -994.91% in the prior-year period — up 167.5% year over year. That is above the sector sector average of 19.62%. Stockcircle updates this page with the newest filings so you can track how the metric evolves quarter by quarter.

Bellevue Life Sciences Acquisition - Units (1 Ord, 1 War & 1 Right ) reported 671.56% in profit margin versus -994.91% a year earlier — a 167.5% year-over-year increase. The historical chart on this page makes it easier to see whether that move is part of a longer pattern.

Bellevue Life Sciences Acquisition - Units (1 Ord, 1 War & 1 Right ) sits higher the its sector benchmark (19.62%) with a profit margin of 671.56%. That is roughly 3322.9% above the sector mean. Peer context matters because what looks expensive or cheap in absolute terms can be normal for the sector.

A profit margin of 671.56% for Bellevue Life Sciences Acquisition - Units (1 Ord, 1 War & 1 Right ) means each unit of related capital or sales is generating that return rate. Higher is usually better for profitability metrics, but extremely high figures can reflect one-time items or thin equity bases. Review several years of data on this page before extrapolating.

The history chart shows how Bellevue Life Sciences Acquisition - Units (1 Ord, 1 War & 1 Right )'s profit margin evolved across reporting periods, while the comparison chart places BLACU next to similar companies. Use both: a rising metric that still lags peers tells a different story than a rising metric that already leads the group. Growth charts, when available, highlight acceleration or slowdown.